Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Two single nucleotide polymorphisms (SNPs) at 6q25.1, near the ESR1 gene, have been implicated in the susceptibility to breast cancer for Asian (rs2046210) and European women (rs9397435). A genome-wide association study in Europeans identified two further breast cancer susceptibility variants: rs112...

Descripción completa

Detalles Bibliográficos
Autores: Antoniou, AC; Kartsonaki, C; Sinilnikova, OM; Soucy, P; McGuffog, L; Healey, S; Lee, A; Peterlongo, P; Manoukian, S; Peissel, B; Zaffaroni, D; Cattaneo, E; Barile, M; Pensotti, V; Pasini, B; Dolcetti, R; Giannini, G; Putignano, AL; Varesco, L; Radice, P; Mai, PL; Greene, MH; Andrulis, IL; Glendon, G; Ozcelik, H; Thomassen, M; Gerdes, AM; Kruse, TA; Jensen, UB; Cruger, DG; Caligo, MA; Laitman, Y; Milgrom, R; Kaufman, B; Paluch-Shimon, S; Friedman, E; Loman, N; Harbst, K; Lindblom, A; Arver, B; Ehrencrona, H; Melin, B; Nathanson, KL; Domchek, SM; Rebbeck, T; Jakubowska, A; Lubinski, J; Gronwald, J; Huzarski, T; Byrski, T; Cybulski, C; Gorski, B; Osorio, A; Cajal, TRY; Fostira, F; Andres, R; Benitez, J; Hamann, U; Hogervorst, FB; Rookus, MA; Hooning, MJ; Nelen, MR; van der Luijt, RB; van Os, TAM; van Asperen, CJ; Devilee, P; Meijers-Heijboer, HEJ; Garcia, EBG; Peock, S; Cook, M; Frost, D; Platte, R; Leyland, J; Evans, DG; Lalloo, F; Eeles, R; Izatt, L; Adlard, J; Davidson, R; Eccles, D; Ong, KR; Cook, J; Douglas, F; Paterson, J; Kennedy, MJ; Miedzybrodzka, Z; Godwin, A; Stoppa-Lyonnet, D; Buecher, B; Belotti, M; Tirapo, C; Mazoyer, S; Barjhoux, L; Lasset, C; Leroux, D; Faivre, L; Bronner, M; Prieur, F; Nogues, C; Rouleau, E; Pujol, P; Coupier, I; Frenay, M; Hopper, JL; Daly, MB; Terry, MB; John, EM; Buys, SS; Yassin, Y; Miron, A; Goldgar, D; Singer, CF; Tea, MK; Pfeiler, G; Dressler, AC; Hansen, TV; Jonson, L; Ejlertsen, B; Barkardottir, RB; Kirchhoff, T; Offit, K; Piedmonte, M; Rodriguez, G; Small, L; Boggess, J; Blank, S; Basil, J; Azodi, M; Toland, AE; Montagna, M; Tognazzo, S; Agata, S; Imyanitov, E; Janavicius, R; Lazaro, C; Blanco, I; Pharoah, PDP; Sucheston, L; Karlan, BY; Walsh, CS; Olah, E; Bozsik, A; Teo, SH; Seldon, JL; Beattie, MS; van Rensburg, EJ; Sluiter, MD; Diez, O; Schmutzler, RK; Wappenschmidt, B; Engel, C; Meindl, A; Ruehl, I; Varon-Mateeva, R; Kast, K; Deissler, H; Niederacher, D; Arnold, N; Gadzicki, D; Schonbuchner, I; Caldes, T; de la Hoya, M; Nevanlinna, H; Aittomaki, K; Dumont, M; Chiquette, J; Tischkowitz, M; Chen, XQ; Beesley, J; Spurdle, AB; Neuhausen, SL; Ding, YC; Fredericksen, Z; Wang, X; Pankratz, VS; Couch, F; Simard, J; Easton, DF; Chenevix-Trench, G
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2011
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p11832
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11832
Nivel de acceso:Acceso abierto
_version_ 1878735125373517824
author Antoniou, AC
author2 Kartsonaki, C
Sinilnikova, OM
Soucy, P
McGuffog, L
Healey, S
Lee, A
Peterlongo, P
Manoukian, S
Peissel, B
Zaffaroni, D
Cattaneo, E
Barile, M
Pensotti, V
Pasini, B
Dolcetti, R
Giannini, G
Putignano, AL
Varesco, L
Radice, P
Mai, PL
Greene, MH
Andrulis, IL
Glendon, G
Ozcelik, H
Thomassen, M
Gerdes, AM
Kruse, TA
Jensen, UB
Cruger, DG
Caligo, MA
Laitman, Y
Milgrom, R
Kaufman, B
Paluch-Shimon, S
Friedman, E
Loman, N
Harbst, K
Lindblom, A
Arver, B
Ehrencrona, H
Melin, B
Nathanson, KL
Domchek, SM
Rebbeck, T
Jakubowska, A
Lubinski, J
Gronwald, J
Huzarski, T
Byrski, T
Cybulski, C
Gorski, B
Osorio, A
Cajal, TRY
Fostira, F
Andres, R
Benitez, J
Hamann, U
Hogervorst, FB
Rookus, MA
Hooning, MJ
Nelen, MR
van der Luijt, RB
van Os, TAM
van Asperen, CJ
Devilee, P
Meijers-Heijboer, HEJ
Garcia, EBG
Peock, S
Cook, M
Frost, D
Platte, R
Leyland, J
Evans, DG
Lalloo, F
Eeles, R
Izatt, L
Adlard, J
Davidson, R
Eccles, D
Ong, KR
Cook, J
Douglas, F
Paterson, J
Kennedy, MJ
Miedzybrodzka, Z
Godwin, A
Stoppa-Lyonnet, D
Buecher, B
Belotti, M
Tirapo, C
Mazoyer, S
Barjhoux, L
Lasset, C
Leroux, D
Faivre, L
Bronner, M
Prieur, F
Nogues, C
Rouleau, E
Pujol, P
Coupier, I
Frenay, M
Hopper, JL
Daly, MB
Terry, MB
John, EM
Buys, SS
Yassin, Y
Miron, A
Goldgar, D
Singer, CF
Tea, MK
Pfeiler, G
Dressler, AC
Hansen, TV
Jonson, L
Ejlertsen, B
Barkardottir, RB
Kirchhoff, T
Offit, K
Piedmonte, M
Rodriguez, G
Small, L
Boggess, J
Blank, S
Basil, J
Azodi, M
Toland, AE
Montagna, M
Tognazzo, S
Agata, S
Imyanitov, E
Janavicius, R
Lazaro, C
Blanco, I
Pharoah, PDP
Sucheston, L
Karlan, BY
Walsh, CS
Olah, E
Bozsik, A
Teo, SH
Seldon, JL
Beattie, MS
van Rensburg, EJ
Sluiter, MD
Diez, O
Schmutzler, RK
Wappenschmidt, B
Engel, C
Meindl, A
Ruehl, I
Varon-Mateeva, R
Kast, K
Deissler, H
Niederacher, D
Arnold, N
Gadzicki, D
Schonbuchner, I
Caldes, T
de la Hoya, M
Nevanlinna, H
Aittomaki, K
Dumont, M
Chiquette, J
Tischkowitz, M
Chen, XQ
Beesley, J
Spurdle, AB
Neuhausen, SL
Ding, YC
Fredericksen, Z
Wang, X
Pankratz, VS
Couch, F
Simard, J
Easton, DF
Chenevix-Trench, G
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Adlard, J
Agata, S
Aittomaki, K
Andres, R
Andrulis, IL
Antoniou, AC
Arnold, N
Arver, B
Azodi, M
Barile, M
Barjhoux, L
Barkardottir, RB
Basil, J
Beattie, MS
Beesley, J
Belotti, M
Benitez, J
Blanco, I
Blank, S
Boggess, J
Bozsik, A
Bronner, M
Buecher, B
Buys, SS
Byrski, T
Cajal, TRY
Caldes, T
Caligo, MA
Cattaneo, E
Chen, XQ
Chenevix-Trench, G
Chiquette, J
Cook, J
Cook, M
Couch, F
Coupier, I
Cruger, DG
Cybulski, C
Daly, MB
Davidson, R
Deissler, H
Devilee, P
Diez, O
Ding, YC
Dolcetti, R
Domchek, SM
Douglas, F
Dressler, AC
Dumont, M
Easton, DF
Eccles, D
Eeles, R
Ehrencrona, H
Ejlertsen, B
Engel, C
Evans, DG
Faivre, L
Fostira, F
Fredericksen, Z
Frenay, M
Friedman, E
Frost, D
Gadzicki, D
Garcia, EBG
Gerdes, AM
Giannini, G
Glendon, G
Godwin, A
Goldgar, D
Gorski, B
Greene, MH
Gronwald, J
Hamann, U
Hansen, TV
Harbst, K
Healey, S
Hogervorst, FB
Hooning, MJ
Hopper, JL
Huzarski, T
Imyanitov, E
Izatt, L
Jakubowska, A
Janavicius, R
Jensen, UB
John, EM
Jonson, L
Karlan, BY
Kartsonaki, C
Kast, K
Kaufman, B
Kennedy, MJ
Kirchhoff, T
Kruse, TA
Laitman, Y
Lalloo, F
Lasset, C
Lazaro, C
Lee, A
Leroux, D
Leyland, J
Lindblom, A
Loman, N
Lubinski, J
Mai, PL
Manoukian, S
Mazoyer, S
McGuffog, L
Meijers-Heijboer, HEJ
Meindl, A
Melin, B
Miedzybrodzka, Z
Milgrom, R
Miron, A
Montagna, M
Nathanson, KL
Nelen, MR
Neuhausen, SL
Nevanlinna, H
Niederacher, D
Nogues, C
Offit, K
Olah, E
Ong, KR
Osorio, A
Ozcelik, H
Paluch-Shimon, S
Pankratz, VS
Pasini, B
Paterson, J
Peissel, B
Pensotti, V
Peock, S
Peterlongo, P
Pfeiler, G
Pharoah, PDP
Piedmonte, M
Platte, R
Prieur, F
Pujol, P
Putignano, AL
Radice, P
Rebbeck, T
Rodriguez, G
Rookus, MA
Rouleau, E
Ruehl, I
Schmutzler, RK
Schonbuchner, I
Seldon, JL
Simard, J
Singer, CF
Sinilnikova, OM
Sluiter, MD
Small, L
Soucy, P
Spurdle, AB
Stoppa-Lyonnet, D
Sucheston, L
Tea, MK
Teo, SH
Terry, MB
Thomassen, M
Tirapo, C
Tischkowitz, M
Tognazzo, S
Toland, AE
Varesco, L
Varon-Mateeva, R
Walsh, CS
Wang, X
Wappenschmidt, B
Yassin, Y
Zaffaroni, D
de la Hoya, M
van Asperen, CJ
van Os, TAM
van Rensburg, EJ
van der Luijt, RB
author_facet Antoniou, AC
Kartsonaki, C
Sinilnikova, OM
Soucy, P
McGuffog, L
Healey, S
Lee, A
Peterlongo, P
Manoukian, S
Peissel, B
Zaffaroni, D
Cattaneo, E
Barile, M
Pensotti, V
Pasini, B
Dolcetti, R
Giannini, G
Putignano, AL
Varesco, L
Radice, P
Mai, PL
Greene, MH
Andrulis, IL
Glendon, G
Ozcelik, H
Thomassen, M
Gerdes, AM
Kruse, TA
Jensen, UB
Cruger, DG
Caligo, MA
Laitman, Y
Milgrom, R
Kaufman, B
Paluch-Shimon, S
Friedman, E
Loman, N
Harbst, K
Lindblom, A
Arver, B
Ehrencrona, H
Melin, B
Nathanson, KL
Domchek, SM
Rebbeck, T
Jakubowska, A
Lubinski, J
Gronwald, J
Huzarski, T
Byrski, T
Cybulski, C
Gorski, B
Osorio, A
Cajal, TRY
Fostira, F
Andres, R
Benitez, J
Hamann, U
Hogervorst, FB
Rookus, MA
Hooning, MJ
Nelen, MR
van der Luijt, RB
van Os, TAM
van Asperen, CJ
Devilee, P
Meijers-Heijboer, HEJ
Garcia, EBG
Peock, S
Cook, M
Frost, D
Platte, R
Leyland, J
Evans, DG
Lalloo, F
Eeles, R
Izatt, L
Adlard, J
Davidson, R
Eccles, D
Ong, KR
Cook, J
Douglas, F
Paterson, J
Kennedy, MJ
Miedzybrodzka, Z
Godwin, A
Stoppa-Lyonnet, D
Buecher, B
Belotti, M
Tirapo, C
Mazoyer, S
Barjhoux, L
Lasset, C
Leroux, D
Faivre, L
Bronner, M
Prieur, F
Nogues, C
Rouleau, E
Pujol, P
Coupier, I
Frenay, M
Hopper, JL
Daly, MB
Terry, MB
John, EM
Buys, SS
Yassin, Y
Miron, A
Goldgar, D
Singer, CF
Tea, MK
Pfeiler, G
Dressler, AC
Hansen, TV
Jonson, L
Ejlertsen, B
Barkardottir, RB
Kirchhoff, T
Offit, K
Piedmonte, M
Rodriguez, G
Small, L
Boggess, J
Blank, S
Basil, J
Azodi, M
Toland, AE
Montagna, M
Tognazzo, S
Agata, S
Imyanitov, E
Janavicius, R
Lazaro, C
Blanco, I
Pharoah, PDP
Sucheston, L
Karlan, BY
Walsh, CS
Olah, E
Bozsik, A
Teo, SH
Seldon, JL
Beattie, MS
van Rensburg, EJ
Sluiter, MD
Diez, O
Schmutzler, RK
Wappenschmidt, B
Engel, C
Meindl, A
Ruehl, I
Varon-Mateeva, R
Kast, K
Deissler, H
Niederacher, D
Arnold, N
Gadzicki, D
Schonbuchner, I
Caldes, T
de la Hoya, M
Nevanlinna, H
Aittomaki, K
Dumont, M
Chiquette, J
Tischkowitz, M
Chen, XQ
Beesley, J
Spurdle, AB
Neuhausen, SL
Ding, YC
Fredericksen, Z
Wang, X
Pankratz, VS
Couch, F
Simard, J
Easton, DF
Chenevix-Trench, G
author_role author
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
description Two single nucleotide polymorphisms (SNPs) at 6q25.1, near the ESR1 gene, have been implicated in the susceptibility to breast cancer for Asian (rs2046210) and European women (rs9397435). A genome-wide association study in Europeans identified two further breast cancer susceptibility variants: rs11249433 at 1p11.2 and rs999737 in RAD51L1 at 14q24.1. Although previously identified breast cancer susceptibility variants have been shown to be associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, the involvement of these SNPs to breast cancer susceptibility in mutation carriers is currently unknown. To address this, we genotyped these SNPs in BRCA1 and BRCA2 mutation carriers from 42 studies from the Consortium of Investigators of Modifiers of BRCA1/2. In the analysis of 14 123 BRCA1 and 8053 BRCA2 mutation carriers of European ancestry, the 6q25.1 SNPs (r(2) = 0.14) were independently associated with the risk of breast cancer for BRCA1 mutation carriers [ hazard ratio (HR) = 1.17, 95% confidence interval (CI): 1.11-1.23, P-trend = 4.5 x 10(-9) for rs2046210; HR = 1.28, 95% CI: 1.18-1.40, P-trend = 1.3 x 10(-8) for rs9397435], but only rs9397435 was associated with the risk for BRCA2 carriers (HR = 1.14, 95% CI: 1.01-1.28, P-trend = 0.031). SNP rs11249433 (1p11.2) was associated with the risk of breast cancer for BRCA2 mutation carriers (HR = 1.09, 95% CI: 1.02-1.17, P-trend = 0.015), but was not associated with breast cancer risk for BRCA1 mutation carriers (HR = 0.97, 95% CI: 0.92-1.02, P-trend = 0.20). SNP rs999737 (RAD51L1) was not associated with breast cancer risk for either BRCA1 or BRCA2 mutation carriers (P-trend = 0.27 and 0.30, respectively). The identification of SNPs at 6q25.1 associated with breast cancer risk for BRCA1 mutation carriers will lead to a better understanding of the biology of tumour development in these women.
eu_rights_str_mv openAccess
format article
id ES_76795e69a013a6bfcae2a125331cfd61
institution Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p11832
publishDate 2011
publishDateSort 2011
publisher OXFORD UNIV PRESS
publisherStr OXFORD UNIV PRESS
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
spelling Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers Antoniou, AC Kartsonaki, C Sinilnikova, OM Soucy, P McGuffog, L Healey, S Lee, A Peterlongo, P Manoukian, S Peissel, B Zaffaroni, D Cattaneo, E Barile, M Pensotti, V Pasini, B Dolcetti, R Giannini, G Putignano, AL Varesco, L Radice, P Mai, PL Greene, MH Andrulis, IL Glendon, G Ozcelik, H Thomassen, M Gerdes, AM Kruse, TA Jensen, UB Cruger, DG Caligo, MA Laitman, Y Milgrom, R Kaufman, B Paluch-Shimon, S Friedman, E Loman, N Harbst, K Lindblom, A Arver, B Ehrencrona, H Melin, B Nathanson, KL Domchek, SM Rebbeck, T Jakubowska, A Lubinski, J Gronwald, J Huzarski, T Byrski, T Cybulski, C Gorski, B Osorio, A Cajal, TRY Fostira, F Andres, R Benitez, J Hamann, U Hogervorst, FB Rookus, MA Hooning, MJ Nelen, MR van der Luijt, RB van Os, TAM van Asperen, CJ Devilee, P Meijers-Heijboer, HEJ Garcia, EBG Peock, S Cook, M Frost, D Platte, R Leyland, J Evans, DG Lalloo, F Eeles, R Izatt, L Adlard, J Davidson, R Eccles, D Ong, KR Cook, J Douglas, F Paterson, J Kennedy, MJ Miedzybrodzka, Z Godwin, A Stoppa-Lyonnet, D Buecher, B Belotti, M Tirapo, C Mazoyer, S Barjhoux, L Lasset, C Leroux, D Faivre, L Bronner, M Prieur, F Nogues, C Rouleau, E Pujol, P Coupier, I Frenay, M Hopper, JL Daly, MB Terry, MB John, EM Buys, SS Yassin, Y Miron, A Goldgar, D Singer, CF Tea, MK Pfeiler, G Dressler, AC Hansen, TV Jonson, L Ejlertsen, B Barkardottir, RB Kirchhoff, T Offit, K Piedmonte, M Rodriguez, G Small, L Boggess, J Blank, S Basil, J Azodi, M Toland, AE Montagna, M Tognazzo, S Agata, S Imyanitov, E Janavicius, R Lazaro, C Blanco, I Pharoah, PDP Sucheston, L Karlan, BY Walsh, CS Olah, E Bozsik, A Teo, SH Seldon, JL Beattie, MS van Rensburg, EJ Sluiter, MD Diez, O Schmutzler, RK Wappenschmidt, B Engel, C Meindl, A Ruehl, I Varon-Mateeva, R Kast, K Deissler, H Niederacher, D Arnold, N Gadzicki, D Schonbuchner, I Caldes, T de la Hoya, M Nevanlinna, H Aittomaki, K Dumont, M Chiquette, J Tischkowitz, M Chen, XQ Beesley, J Spurdle, AB Neuhausen, SL Ding, YC Fredericksen, Z Wang, X Pankratz, VS Couch, F Simard, J Easton, DF Chenevix-Trench, G Two single nucleotide polymorphisms (SNPs) at 6q25.1, near the ESR1 gene, have been implicated in the susceptibility to breast cancer for Asian (rs2046210) and European women (rs9397435). A genome-wide association study in Europeans identified two further breast cancer susceptibility variants: rs11249433 at 1p11.2 and rs999737 in RAD51L1 at 14q24.1. Although previously identified breast cancer susceptibility variants have been shown to be associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, the involvement of these SNPs to breast cancer susceptibility in mutation carriers is currently unknown. To address this, we genotyped these SNPs in BRCA1 and BRCA2 mutation carriers from 42 studies from the Consortium of Investigators of Modifiers of BRCA1/2. In the analysis of 14 123 BRCA1 and 8053 BRCA2 mutation carriers of European ancestry, the 6q25.1 SNPs (r(2) = 0.14) were independently associated with the risk of breast cancer for BRCA1 mutation carriers [ hazard ratio (HR) = 1.17, 95% confidence interval (CI): 1.11-1.23, P-trend = 4.5 x 10(-9) for rs2046210; HR = 1.28, 95% CI: 1.18-1.40, P-trend = 1.3 x 10(-8) for rs9397435], but only rs9397435 was associated with the risk for BRCA2 carriers (HR = 1.14, 95% CI: 1.01-1.28, P-trend = 0.031). SNP rs11249433 (1p11.2) was associated with the risk of breast cancer for BRCA2 mutation carriers (HR = 1.09, 95% CI: 1.02-1.17, P-trend = 0.015), but was not associated with breast cancer risk for BRCA1 mutation carriers (HR = 0.97, 95% CI: 0.92-1.02, P-trend = 0.20). SNP rs999737 (RAD51L1) was not associated with breast cancer risk for either BRCA1 or BRCA2 mutation carriers (P-trend = 0.27 and 0.30, respectively). The identification of SNPs at 6q25.1 associated with breast cancer risk for BRCA1 mutation carriers will lead to a better understanding of the biology of tumour development in these women. OXFORD UNIV PRESS https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11832
spellingShingle Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
Antoniou, AC
status_str publishedVersion
title Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
title_full Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
title_fullStr Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
title_full_unstemmed Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
title_short Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
title_sort Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11832